Flutamide in the Treatment of Metastatic Carcinoma of the Prostate
- 1 April 1981
- journal article
- research article
- Published by Wiley in British Journal of Urology
- Vol. 53 (2) , 152-153
- https://doi.org/10.1111/j.1464-410x.1981.tb03157.x
Abstract
SUMMARY— Twenty-five patients with metastatic carcinoma of the prostate were treated with Flutamide, a non-steroidal anti-androgen. All patients showed progression; the longest response was 1 20 weeks. The side effects were nausea, vomiting, breast tenderness and gynaecomastia.This publication has 3 references indexed in Scilit:
- Comparison of flutamide (SCH-13521) and diethylstilbestrol in untreated advanced prostatic cancerUrology, 1976
- Prostatic Cancer and Sch-13521: II. Histological Alterations and the Pituitary Gonadal AxisJournal of Urology, 1975
- Sch 13521 In The Treatment Of Advanced Carcinoma Of The ProstateJournal of Urology, 1974